Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria A Streltsova

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Journal of Leukocyte Biology|May 19, 2020
HLA-DR-expressing NK cells: Effective killers suspected for antigen presentationSofya A Erokhina, Maria A Streltsova, Leonid M Kanevskiy, et al.
Biomolecules|April 2, 2020
Activation of α7 Nicotinic Acetylcholine Receptor Upregulates HLA-DR and Macrophage Receptors: Potential Role in Adaptive Immunity and in Preventing ImmunosuppressionAndrei E Siniavin, Maria A Streltsova, Denis S Kudryavtsev, et al.
Biomedicines|July 2, 2021
Telomerase Reverse Transcriptase Increases Proliferation and Lifespan of Human NK Cells without ImmortalizationMaria A Streltsova, Maria O Ustiuzhanina, Eugene V Barsov, et al.
Biomolecules|September 28, 2023
Epithelial-Immune Cell Crosstalk Determines the Activation of Immune Cells In Vitro by the Human Cathelicidin LL-37 at Low Physiological ConcentrationsIvan V Bogdanov, Maria A Streltsova, Elena I Kovalenko, et al.
Journal of Immunology Research|June 26, 2019
The Role of O-Antigen in LPS-Induced Activation of Human NK CellsLeonid M Kanevskiy, Sofya A Erokhina, Maria A Streltsova, et al.
Immune Network|May 11, 2026
In Search of Adaptive-Like Features of NK Cells Co-Expressing NKG2C and NKG2ANadezhda A Alekseeva, Maria O Ustiuzhanina, Julia D Vavilova, et al.
Cell Death Discovery|June 12, 2026
Interplay of telomerase non-canonical functions in NK cell resistance to iCasp9-mediated apoptosisAnastasia I Palamarchuk, Maria O Ustiuzhanina, Rodion A Velichinskii, et al.
Cytotherapy|September 13, 2025
PSCA-CAR-NK cells exert cytotoxic activity against PSCA-expressing tumor cells and are characterized by a specific chemokine profileRodion A Velichinskii, Maria A Streltsova, Julia D Vavilova, et al.
Journal of Leukocyte Biology|September 15, 2020
CD56<sup>dim</sup> CD57<sup>-</sup> NKG2C<sup>+</sup> NK cells retaining proliferative potential are possible precursors of CD57<sup>+</sup> NKG2C<sup>+</sup> memory-like NK cellsPolina A Kobyzeva, Maria A Streltsova, Sofya A Erokhina, et al.
Plos One|December 6, 2018
Analysis of NK cell clones obtained using interleukin-2 and gene-modified K562 cells revealed the ability of "senescent" NK cells to lose CD57 expression and start expressing NKG2AMaria A Streltsova, Sofya A Erokhina, Leonid M Kanevskiy, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Journal of Leukocyte Biology|May 19, 2020
HLA-DR-expressing NK cells: Effective killers suspected for antigen presentationSofya A Erokhina, Maria A Streltsova, Leonid M Kanevskiy, et al.
Biomolecules|April 2, 2020
Activation of α7 Nicotinic Acetylcholine Receptor Upregulates HLA-DR and Macrophage Receptors: Potential Role in Adaptive Immunity and in Preventing ImmunosuppressionAndrei E Siniavin, Maria A Streltsova, Denis S Kudryavtsev, et al.
Biomedicines|July 2, 2021
Telomerase Reverse Transcriptase Increases Proliferation and Lifespan of Human NK Cells without ImmortalizationMaria A Streltsova, Maria O Ustiuzhanina, Eugene V Barsov, et al.
Biomolecules|September 28, 2023
Epithelial-Immune Cell Crosstalk Determines the Activation of Immune Cells In Vitro by the Human Cathelicidin LL-37 at Low Physiological ConcentrationsIvan V Bogdanov, Maria A Streltsova, Elena I Kovalenko, et al.
Journal of Immunology Research|June 26, 2019
The Role of O-Antigen in LPS-Induced Activation of Human NK CellsLeonid M Kanevskiy, Sofya A Erokhina, Maria A Streltsova, et al.
Immune Network|May 11, 2026
In Search of Adaptive-Like Features of NK Cells Co-Expressing NKG2C and NKG2ANadezhda A Alekseeva, Maria O Ustiuzhanina, Julia D Vavilova, et al.
Cell Death Discovery|June 12, 2026
Interplay of telomerase non-canonical functions in NK cell resistance to iCasp9-mediated apoptosisAnastasia I Palamarchuk, Maria O Ustiuzhanina, Rodion A Velichinskii, et al.
Cytotherapy|September 13, 2025
PSCA-CAR-NK cells exert cytotoxic activity against PSCA-expressing tumor cells and are characterized by a specific chemokine profileRodion A Velichinskii, Maria A Streltsova, Julia D Vavilova, et al.
Journal of Leukocyte Biology|September 15, 2020
CD56<sup>dim</sup> CD57<sup>-</sup> NKG2C<sup>+</sup> NK cells retaining proliferative potential are possible precursors of CD57<sup>+</sup> NKG2C<sup>+</sup> memory-like NK cellsPolina A Kobyzeva, Maria A Streltsova, Sofya A Erokhina, et al.
Plos One|December 6, 2018
Analysis of NK cell clones obtained using interleukin-2 and gene-modified K562 cells revealed the ability of "senescent" NK cells to lose CD57 expression and start expressing NKG2AMaria A Streltsova, Sofya A Erokhina, Leonid M Kanevskiy, et al.
Pageof 4